The VanEck Pharmaceutical ETF (NYSEARCA:PPH) has surged 26% over the past year, driven almost entirely by the weight-loss ...
VanEck Pharmaceutical ETF offers focused exposure to large-cap pharmaceutical companies, benefiting from strong long-term demographic and innovation trends. PPH's high concentration in top holdings ...
The VanEck Pharmaceutical ETF provides diversified exposure to the world's largest pharmaceutical companies, focusing on 'big pharma' through a cap-weighted index. PPH tracks the MVIS US Listed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results